AAAAAA
Results: 1-25/30
Authors:
Bennett, CF
Citation: Cf. Bennett, Antisense therapy, PROG R RES, 31, 2001, pp. 365-369
Authors:
Condon, TP
Flournoy, S
Sawyer, GJ
Baker, BF
Kishimoto, TK
Bennett, CF
Citation: Tp. Condon et al., ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes, ANTISENSE N, 11(2), 2001, pp. 107-116
Authors:
Vickers, TA
Wyatt, JR
Burckin, T
Bennett, CF
Freier, SM
Citation: Ta. Vickers et al., Fully modified 2 ' MOE oligonucleotides redirect polyadenylation, NUCL ACID R, 29(6), 2001, pp. 1293-1299
Authors:
Stepkowski, SM
Chen, W
Geary, R
Yang, ME
Condon, T
Stecker, K
Bennett, CF
Citation: Sm. Stepkowski et al., Development of an oral formulation for ICAM-1 antisense oligonucleotides, TRANSPLAN P, 33(1-2), 2001, pp. 387-387
Authors:
Chen, W
Bennett, CF
Condon, TP
Stecker, K
Tian, L
Kahan, BD
Stepkowski, SM
Citation: W. Chen et al., Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury, TRANSPLAN P, 33(1-2), 2001, pp. 854-854
Authors:
Qu, X
Kirken, RA
Tian, L
Wang, ME
Bennett, CF
Stepkowski, SM
Citation: X. Qu et al., Selective inhibition of IL-2 gene expression by IL-2 antisense oligonucleotides blocks heart allograft rejection, TRANSPLANT, 72(5), 2001, pp. 915-923
Authors:
Bannerman, DD
Tupper, JC
Ricketts, WA
Bennett, CF
Winn, RK
Harlan, JM
Citation: Dd. Bannerman et al., A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis, J BIOL CHEM, 276(18), 2001, pp. 14924-14932
Authors:
Yacyshyn, BR
Bowen-Yacyshyn, MB
Jewell, L
Tami, JA
Bennett, CF
Kisner, DL
Shanahan, WR
Citation: Br. Yacyshyn et al., A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. (vol 114, pg 1133, 1998), GASTROENTY, 121(3), 2001, pp. 747-747
Authors:
Mesri, M
Morales-Ruiz, M
Ackermann, EJ
Bennett, CF
Pober, JS
Sessa, WC
Altieri, DC
Citation: M. Mesri et al., Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting, AM J PATH, 158(5), 2001, pp. 1757-1765
Authors:
Bennett, CF
Citation: Cf. Bennett, General pharmacology of phosphorothioate oligodeoxynucleotides, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 291-318
Authors:
Templin, MV
Levin, AA
Graham, MJ
Aberg, PM
Axelsson, BI
Butler, M
Geary, RS
Bennett, CF
Citation: Mv. Templin et al., Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotidefollowing inhalation delivery to lung in mice, ANTISENSE N, 10(5), 2000, pp. 359-368
Authors:
Clark, R
Byatt, SA
Bennett, CF
Brama, M
Martineau, M
Moorman, AV
Roberts, K
Secker-Walker, LM
Richards, S
Eden, OB
Goldstone, AH
Harrison, CJ
Citation: R. Clark et al., Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia, LEUKEMIA, 14(2), 2000, pp. 241-246
Authors:
Lorenz, P
Misteli, T
Baker, BF
Bennett, CF
Spector, DL
Citation: P. Lorenz et al., Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides, NUCL ACID R, 28(2), 2000, pp. 582-592
Inhibition of C-raf expression by antisense oligonucleotides extends heartallograft survival in rats
Authors:
Stepkowski, SM
Qu, XM
Wang, ME
Tian, L
Chen, WH
Wancewicz, EV
Johnston, JF
Bennett, CF
Monia, BP
Citation: Sm. Stepkowski et al., Inhibition of C-raf expression by antisense oligonucleotides extends heartallograft survival in rats, TRANSPLANT, 70(4), 2000, pp. 656-661
Authors:
Knight, DA
Briggs, BR
Bennett, CF
Harindranath, N
Waldman, WJ
Sedmak, DD
Citation: Da. Knight et al., Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2 '-O-methoxyethyl antisense oligonucleotide, TRANSPLANT, 69(3), 2000, pp. 417-426
Authors:
Bennett, CF
Citation: Cf. Bennett, Water and man on the Varzea of Careiro, Vol 1., PROF GEOGR, 52(4), 2000, pp. 770-771
Authors:
Henry, S
Stecker, K
Brooks, D
Monteith, D
Conklin, B
Bennett, CF
Citation: S. Henry et al., Chemically modified oligonucleotides exhibit decreased immune stimulation in mice, J PHARM EXP, 292(2), 2000, pp. 468-479
Authors:
Klimuk, SK
Semple, SC
Nahirney, PN
Mullen, MC
Bennett, CF
Scherrer, P
Hope, MJ
Citation: Sk. Klimuk et al., Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity, J PHARM EXP, 292(2), 2000, pp. 480-488
Authors:
Butler, M
Crooke, RM
Graham, MJ
Lemonidis, KM
Lougheed, M
Murray, SF
Witchell, D
Steinbrecher, U
Bennett, CF
Citation: M. Butler et al., Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice, J PHARM EXP, 292(2), 2000, pp. 489-496
Authors:
Mehta, RC
Stecker, KK
Cooper, SR
Templin, MV
Tsai, YJ
Condon, TP
Bennett, CF
Hardee, GE
Citation: Rc. Mehta et al., Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides, J INVES DER, 115(5), 2000, pp. 805-812
Authors:
Bennett, CF
Butler, M
Cook, PD
Geary, RS
Levin, AA
Mehta, R
Teng, CL
Deshmukh, H
Tillman, L
Hardee, G
Citation: Cf. Bennett et al., Antisense oligonucleotide-based therapeutics, GENE THERAPY, 2000, pp. 305-332
Authors:
Li, FZ
Ackermann, EJ
Bennett, CF
Rothermel, AL
Plescia, J
Tognin, S
Villa, A
Marchisio, PC
Altieri, DC
Citation: Fz. Li et al., Pleiotropic cell-division defects and apoptosis induced by interference with survivin function, NAT CELL BI, 1(8), 1999, pp. 461-466
Authors:
Bennett, CF
Citation: Cf. Bennett, Regulation of immune response with antisense oligonucleotides, ANTISENSE N, 9(4), 1999, pp. 423-427
Authors:
Bhat, B
Heber't, N
Marcusson, EG
Dean, NM
Bennett, CF
Manoharan, M
Citation: B. Bhat et al., Synthesis of fluorescent cationic lipids for evaluation of cellular pathways and delivery mechanisms of antisense oligonucleotides, NUCLEOS NUC, 18(6-7), 1999, pp. 1727-1728
Authors:
Witters, L
Kumar, R
Mandal, M
Bennett, CF
Miraglia, L
Lipton, A
Citation: L. Witters et al., Antisense oligonucleotides to the epidermal growth factor receptor, BREAST CANC, 53(1), 1999, pp. 41-50